The primary objective of this study is to investigate the neuro-endocrine development of socio-emotional control related to automatic emotional action tendencies, the structural maturation of the brain, and how these contribute to cognitive control…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
The study is not primarily aimed at disoders, but research in healthy adolescents concerning social-emotional control that can have implications for the development of affective disorders (such as anxiety and aggression)
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main parameters in our study are the neural (brain activation patterns) and
behavioral measurements of the control of socio-emotional behavior as well as
indices of grey matter (GM) and white matter (WM) maturation (e.g. volume,
tract strength).
Secondary outcome
Secondary parameters include hormonal measurements (salivary levels of
testosterone, cortisol, and estrogen) and gut microbiota.
Background summary
Socio-emotional control is critical in daily societal functioning. In stressful
or threatening situations this control can fail, with chronic failures
underlying aggression- and anxiety-related disorders. This study will examine
the development of neural activation patterns related to socio-emotional
control. Previous neuroimaging studies have indicated that adolescence is a
critical transition phase where socio-emotional control shifts from subcortical
to cortical control. However, the onset of this shift in adolescence has never
been investigated. We will therefore examine neural control of social-emotional
actions at age 12, which constitutes a critical phase in the transition from
childhood to adolescence.
The BIBO cohort (Basal Influences on the Baby*s Development; Dutch: *Basale
Invloed op de Baby Ontwikkeling*; PI: Prof. Carolina de Weerth) offers a unique
possibility to test this transition and its impact on stress coping, symptoms,
and social-affective behavior and executive control. The current study is a
follow-up of a previous developmental study of social-emotional control from
mid to late adolescence (14-17 years; CMO 2014/104, 2010/420). We now have the
unique opportunity to investigate the developmental status of exactly the same
neural circuits in pre-adolescents (age 12) in this parallel longitudinal
study.
Study objective
The primary objective of this study is to investigate the neuro-endocrine
development of socio-emotional control related to automatic emotional action
tendencies, the structural maturation of the brain, and how these contribute to
cognitive control across adolescence. To this end, participants of the BIBO
cohort, on average 12 years of age, will perform a social-emotional control
task (previously approved for adolescents by CMO 2014/104; 2010/420). A
secondary goal of the study is to relate individual differences in
socio-emotional control, including their neural-endocrine correlates to 1)
various measures of functioning and adjustment (i.e. stress sensitivity,
aggression/anxiety tendencies) assessed at age 12, as well as; 2) earlier
measures within the longitudinal study acquired from infancy (and prenatally)
through childhood.
Study design
This is a consecutive wave of an ongoing longitudinal study. Participants of
the BIBO cohort will be asked to complete a task assessing socio-emotional
control in the MRI scanner while their brain activity is measured using
functional Magnetic Resonance Imaging. We will also acquire structural scans.
Study burden and risks
The risk of participation in this (f)MRI study can be considered negligible
with a minimal burden on the participants. This is a noninvasive technique,
which has been used in children from 8 years of age. Before definite inclusion
the participant will fill out an MRI questionnaire to determine whether the
individual can participate, including all aspects of MRI contra-indication and
claustrophobia. Although there is no direct benefit to the participants from
this proposed research, there are greater benefits to society from the
potential knowledge gained from this study. The knowledge about normal
development is critical in understanding cases of abnormal development in order
to create more effective preventive and therapeutic techniques.
Kapittelweg 29
Nijmegen 6525 EN
NL
Kapittelweg 29
Nijmegen 6525 EN
NL
Listed location countries
Age
Inclusion criteria
- participant of the BIBO Study
- no history of neurological disorder/disease
- no counter-indications for MRI
- right-handed
- capable of understanding the experimental procedures
Exclusion criteria
- history of neurological or psychiatric illness
- history of using psychotropic medications
- severe learning disabilities
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL66477.091.18 |